Introduction Lung cancer is the most frequent neoplasm in humans. Surgery is considered
the best therapeutic approach for stage I non-small lung cell cancer (NSCLC). However, a …

Radiotherapy in Lung Cancer: Current and Future Role Review Page 1 Radiotherapy in Lung
Cancer: Current and Future Role Lung cancer is known to be the most commonly diag- nosed …

Many non-small cell lung cancer (NSCLC) patients initially benefiting from gefitinib are
confronted with acquired resistance. MiR-138 was previously stated as a growth inhibitor of …

Cancer cells release DNA fragments into plasma as circulating free DNA (cfDNA). However,
quantitative measurement of tumor‐derived DNA in cfDNA remains challenge. The purpose …

Non-small-cell lung cancer (NSCLC) dominates over 85% of all lung cancer cases.
Epidermal growth factor receptor (EGFR) activating mutation is a common situation in …

Background: Overexpression of epidermal growth factor receptor (EGFR) has been reported
to be implicated in the pathogenesis of non-small cell lung cancer (NSCLC). Several EGFR …

Background: Neuropilin 1 (NRP1) is a pleiotropic receptor which can interact with multiple
ligands and their receptors. It plays an important role in the process of axonal growth …

Akciğer Kanserinde Radyoterapi: Güncel ve Gelecekteki Rolü Derleme Page 1 Akciğer
Kanserinde Radyoterapi: Güncel ve Gelecekteki Rolü Yazışma Adresi: Esengül Koçak Uzel …

Двумя основными направлениями исследований эффективности лучевой терапии при
немелкоклеточном раке легкого (НМРЛ), позволяющими надеяться на радикальность и …

Активное внедрение скрининговых программ позволяет надеяться на существенное
увеличение доли пациентов с ранними формами немелкоклеточного рака лёгкого …